Table 1.
35SO4- labeled GAG retained in cartilage by the end of the experiment. Samples were treated with different platelet derived products (PL) in different concentrations and compared to controls (using ITS or FBS as medium supplementation)
| Platelet-lysate Product or control | 0-fold (Control) | 1.5-fold | 3-fold | 6-fold |
|---|---|---|---|---|
| Frozen PL | ******* | 46.5137 ± 39.2634 | 85.696 ± 36.1581 | 67.0945 ± 34.8874 |
| Freeze-dried PL | ******* | 68.4964 ± 33.7408 | 146.34 ± 36.2139 | 74.4229 ± 34.8874 |
| Filtered freeze-dried PL | ******* | 166.96 ± 39.2691 | 111.14 ± 36.2195 | 68.5834 ± 34.9405 |
| ITS control | 75.7266 ± 52.7041 | *********** | *********** | *********** |
| FBS control | 79.3627 ± 48.8237 | *********** | *********** | *********** |
No significant difference was observed for the main comparisons of PL*Concentration interaction (P:3053). Values in table represent mean ± standard error of the mean in DPM/ μg of DNA. Level of significance 0.05